Meridian Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
+28,774
New +$1.24M 0.31% 54
2016
Q1
Sell
-111,164
Closed -$3.23M 68
2015
Q4
$3.23M Hold
111,164
2.07% 14
2015
Q3
$3.02M Sell
111,164
-2,826
-2% -$80K 1.98% 14
2015
Q2
$3.12M Sell
113,990
-8,780
-7% -$247K 1.89% 13
2015
Q1
$3.28M Hold
122,770
2.35% 13
2014
Q4
$2.6M Buy
122,770
+3,620
+3% +$80.9K 1.89% 21
2014
Q3
$2.84M Buy
119,150
+900
+0.8% +$20.7K 2.17% 14
2014
Q2
$2.73M Hold
118,250
2.04% 15
2014
Q1
$2.7M Hold
118,250
2.14% 12
2013
Q4
$2.19M Buy
118,250
+39,850
+51% +$694K 1.74% 24
2013
Q3
$1.33M Hold
78,400
1.14% 39
2013
Q2
$1.32M Buy
+78,400
New +$1.3M 1.16% 38

Other funds holding NVO

Meridian Management's NVO Position: Q2 2026 in Review

Meridian Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 28,774 shares worth $1.38M. The stake represents 0.31% of the portfolio and ranks #54 among its holdings. This is a return to the name: Meridian Management previously reported a position in NVO as recently as Q4 2015.

Meridian Management first reported a position in NVO in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.28M in Q1 2015. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Meridian Management held 28,774 shares of Novo Nordisk worth $1.38M as of Q2 2026.
  • Novo Nordisk was a new Meridian Management position in Q2 2026.
  • Novo Nordisk made up 0.31% of Meridian Management's portfolio in Q2 2026, its #54 holding.
  • Meridian Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 12 quarters since.
  • Meridian Management's Novo Nordisk position peaked at $3.28M in Q1 2015.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Meridian Management's 13F filing for Q2 2026, filed 4 Aug 2026.